|
|
 |
|
|
|
Components
| Abbott Laboratories |
ABT |
| Agilent Technologies, Inc. |
A |
| Alcon Inc. |
ALC.SW |
| Align Technology, Inc. |
ALGN |
| Amplifon SpA |
AMP.IM |
| Baxter International Inc. |
BAX |
| Becton, Dickinson and Company |
BDX |
| BioMerieux |
BIM.FP |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
| Boston Scientific Corporation |
BSX |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
| Cochlear Limited |
COH.AU |
| Coloplast A/S (Class B) |
COLOB.DC |
| Danaher Corporation |
DHR |
| Demant A/S |
DEMANT.DC |
| DexCom, Inc. |
DXCM |
| Edwards Lifesciences Corporation |
EW |
| Exact Sciences Corporation |
EXAS |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
| GE HealthCare Technologies Inc. |
GEHC |
| Globus Medical, Inc. (Class A) |
GMED |
| Hologic, Inc. |
HOLX |
| Hoya Corporation |
7741.JP |
| Insulet Corporation |
PODD |
| Intuitive Surgical, Inc. |
ISRG |
| Koninklijke Philips N.V. |
PHIA.NA |
| Masimo Corporation |
MASI |
| Medtronic Plc |
MDT |
| Mettler-Toledo International Inc. |
MTD |
| Olympus Corporation |
7733.JP |
| Penumbra, Inc. |
PEN |
| ResMed Inc. |
RMD |
| Revvity, Inc. |
RVTY |
| Sartorius Stedim Biotech |
DIM.FP |
| Shockwave Medical, Inc. |
SWAV |
| Siemens Healthineers AG |
SHL.GY |
| Smith & Nephew Plc |
SN/.LN |
| Sonova Holding AG (Registered) |
SOON.SW |
| Steris Plc |
STE |
| Straumann Holding AG (Registered) |
STMN.SW |
| Stryker Corporation |
SYK |
| Sysmex Corporation |
6869.JP |
| Teleflex Incorporated |
TFX |
| Terumo Corporation |
4543.JP |
| The Cooper Companies, Inc. |
COO |
| Thermo Fisher Scientific Inc. |
TMO |
| Waters Corporation |
WAT |
| West Pharmaceutical Services, Inc. |
WST |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
| Zimmer Biomet Holdings, Inc. |
ZBH |
|
|
|
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|